Arkolith/Insider Trading/XFOR/Form 4

Ragan Paula

President and CEO, DirectorX4 Pharmaceuticals, Inc (XFOR) · full profile →Form 4 · filed Feb 12, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$22K
Net Open-Market Flow
-$22K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 12, 2024Sell(S)22K$1.01$22K815K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-24-004266) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML